Sandoz to study biosimilar aflibercept in Phase III AMD trial,

Sandoz has plans to begin a late-stage clinical development programme to assess its proposed biosimilar aflibercept, which is developed to improve …, Sandoz has plans to begin a late-stage clinical development programme to assess its proposed biosimilar aflibercept, which is developed to improve …, Read More

Scroll to Top